Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease

被引:2
|
作者
Fujiya, Mikihiro [1 ]
Kawaguchi, Tsutomu [2 ]
Arai, Shoko [2 ]
Isogawa, Naoki [3 ]
Hiro, Shintaro [3 ]
Matsumoto, Fumihiro [2 ]
Yamaguchi, Satoshi [2 ,4 ]
Yoshii, Noritoshi [2 ]
Nakamura, Mashio [5 ]
Matsuoka, Katsuyoshi [6 ]
机构
[1] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan
[2] Pfizer Japan Inc, Immunol & Inflammat Med Affairs, Shinjuku Culture Quint Bldg 3-22-7 Yoy Shibuya Ku, Tokyo 1518589, Japan
[3] Pfizer R&D Japan, Biometr & Data Management, Shinjuku Culture Quint Bldg 3-22-7 Yoy Shibuya Ku, Tokyo 1518589, Japan
[4] Int Univ Hlth & Welf, Tokyo, Japan
[5] Hidamarinooka Nakamura Med Clin, Dept Internal Med Pediat & Cardiol, 7-1510 Hidamarinooka, Kuwana 5110867, Japan
[6] Toho Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sakura Med Ctr, Sakura, Chiba 2850841, Japan
关键词
Incidence; Inflammatory bowel diseases; Japan; Risk factors; Venous thromboembolism; RISK-FACTORS; PREVENTION; PREVALENCE; THROMBOSIS; EVENTS;
D O I
10.1007/s10620-022-07388-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn's disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Aim To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. Methods This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient-years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case-control design. Results Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. Conclusions This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan.
引用
收藏
页码:5195 / 5205
页数:11
相关论文
共 50 条
  • [1] Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
    Mikihiro Fujiya
    Tsutomu Kawaguchi
    Shoko Arai
    Naoki Isogawa
    Shintaro Hiro
    Fumihiro Matsumoto
    Satoshi Yamaguchi
    Noritoshi Yoshii
    Mashio Nakamura
    Katsuyoshi Matsuoka
    [J]. Digestive Diseases and Sciences, 2022, 67 : 5195 - 5205
  • [2] Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Dhaliwal, Galvin
    Patrone, Michael V.
    Bickston, Stephen J.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [3] Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism
    Yamashita, Yugo
    [J]. CIRCULATION JOURNAL, 2023, 87 (09) : 1185 - 1186
  • [4] Venous thromboembolism in Asian patients with inflammatory bowel disease
    Lin, H.
    Lim, W. C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S311 - S312
  • [5] Preventability of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Scoville, Elizabeth
    Konijeti, Gauree
    Yajnik, Vijay
    Nguyen, Deanna
    Sauk, Jenny
    Ananthakrishnan, Ashwin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S511 - S512
  • [6] Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Koutroumpakis, Efstratios I.
    Tsiolakidou, Georgia
    Koutroubakis, Ioannis E.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (05): : 461 - 468
  • [7] Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis
    Daisuke Hirayama
    Shinichiro Hyodo
    Kazuo Morita
    Hiroshi Nakase
    [J]. Journal of Gastroenterology, 2024, 59 : 389 - 401
  • [8] Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis
    Hirayama, Daisuke
    Hyodo, Shinichiro
    Morita, Kazuo
    Nakase, Hiroshi
    [J]. JOURNAL OF GASTROENTEROLOGY, 2024, 59 (05) : 389 - 401
  • [9] Economics of Emergency Department Visits by Patients With Inflammatory Bowel Disease: A Real-World Analysis
    Clarke, Kofi
    Momin, Arsh
    Rosario, Michelle
    Stuart, August
    Dalessio, Shannon
    Tinsley, Andrew
    Williams, Emmanuelle
    Coates, Matthew
    [J]. CROHNS & COLITIS 360, 2024, 6 (02)
  • [10] Venous thromboembolism in inflammatory bowel disease
    Kimberly Cheng
    Adam S Faye
    [J]. World Journal of Gastroenterology, 2020, 26 (12) : 1231 - 1241